Literature DB >> 4550505

Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

G Medoff, G S Kobayashi, C N Kwan, D Schlessinger, P Venkov.   

Abstract

Amphotericin B potentiates the antifungal effects of 5-fluorocytosine and rifampicin, probably by increasing the penetration of these agents through the fungal cytoplasmic membrane.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4550505      PMCID: PMC427574          DOI: 10.1073/pnas.69.1.196

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

Review 1.  Antibiotic interaction with model membranes.

Authors:  S C Kinsky
Journal:  Annu Rev Pharmacol       Date:  1970       Impact factor: 13.820

2.  Studies on the permeability change produced in coliform bacteria by ethylenediaminetetraacetate.

Authors:  L Leive
Journal:  J Biol Chem       Date:  1968-05-10       Impact factor: 5.157

3.  Rifampicin sensitivity of the components of DNA-dependent RNA polymerase.

Authors:  E di Mauro; L Synder; P Marino; A Lamberti; A Coppo; G P Tocchini-Valentini
Journal:  Nature       Date:  1969-05-10       Impact factor: 49.962

4.  Amphotericin B in cryptococcal meningitis. Long-term results of treatment.

Authors:  G A Sarosi; J D Parker; I L Doto; F E Tosh
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

5.  Electrophoretic separation of viral nucleic acids on polyacrylamide gels.

Authors:  D H Bishop; J R Claybrook; S Spiegelman
Journal:  J Mol Biol       Date:  1967-06-28       Impact factor: 5.469

6.  Identification of ten genes that control ribosome formation in yeast.

Authors:  L H Hartwell; C S McLaughlin; J R Warner
Journal:  Mol Gen Genet       Date:  1970

7.  The synthesis and processing of ribosomal RNA precursor molecules in yeast.

Authors:  R L Taber; W S Vincent
Journal:  Biochim Biophys Acta       Date:  1969-08-20

8.  Rifampicin and poxvirus replication.

Authors:  Z Ben-Ishai; E Heller; N Goldblum; Y Becker
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

9.  Covalent integrity and molecular weights of yeast ribosomal ribonucleic acid components.

Authors:  G Bruening; R M Bock
Journal:  Biochim Biophys Acta       Date:  1967-12-19

10.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05
View more
  59 in total

1.  In vitro studies with combinations of 5-fluorocytosine and amphotericin B.

Authors:  S Shadomy; G Wagner; E Espinel-Ingroff; B A Davis
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

2.  Differential potentiation by nystatin of the effect of antibiotics on yeast and mammalian cells.

Authors:  A Aszalos
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

3.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 4.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

5.  In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination.

Authors:  K K Lee; S L Karr; M M Wong; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin.

Authors:  D Rifkind; E D Crowder; R N Hyland
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.

Authors:  M Kitahara; V K Seth; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

9.  The mechanism of inhibition of ribonucleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin.

Authors:  R S Fraser; J Creanor
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

10.  Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.

Authors:  E Titsworth; E Grunberg
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.